190 results on '"de Lemos, James A."'
Search Results
2. Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction
3. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
4. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT
5. Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort
6. National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis
7. Associations Between Cardiac Function and Brain Health in Diverse Middle-Aged Adults: The Dallas Heart Study-2
8. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study
9. Impact of Age and Variant Time Period on Clinical Presentation and Outcomes of Hospitalized Coronavirus Disease 2019 Patients
10. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study
11. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study
12. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
13. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults
14. Exercise Training, Cardiac Biomarkers, and Cardiorespiratory Fitness in Type 2 Diabetes: The HART-D Study
15. 2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department: A Report of the American College of Cardiology Solution Set Oversight Committee
16. Quality of Care Among Patients with Diabetes and Cerebrovascular Disease. Insights from The Diabetes Collaborative Registry
17. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy
18. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
19. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study
20. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study
21. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD
22. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population
23. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults
24. Relations Between Cardiac Magnetic Resonance Imaging-Derived Left Ventricular Mass, Early Repolarization, and Cardiovascular Events (from the Dallas Heart Study)
25. Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes
26. Physical Activity, Subclinical Myocardial Injury, and Risk of Heart Failure Subtypes in Black Adults
27. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)
28. Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes
29. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study
30. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization
31. QuLF-CT: A Radiomics-Based Tool for Quantification of Liver Fat Fraction on Cardiac CT
32. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion
33. Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial
34. Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults
35. Comparison of Readmission Rates After Acute Myocardial Infarction in 3 Patient Age Groups (18 to 44, 45 to 64, and ≥65 Years) in the United States
36. Survival Characteristics of Older Patients Hospitalized With COVID-19: Insights From the American Heart Association COVID-19 Cardiovascular Disease Registry
37. Defining coronary artery calcium concordance and repeatability - Implications for development and change: The Dallas Heart Study
38. Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study
39. Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes
40. Convalescent Phenotyping of Cardiac Injury During Hospitalization for Acute COVID-19
41. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
42. Determinants of Racial/Ethnic Differences in Cardiorespiratory Fitness (from the Dallas Heart Study)
43. Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement
44. Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study)
45. Premature Clopidogrel Discontinuation After Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital
46. Temporal Trends in Left Ventricular Mechanical Unloading With Venoarterial Extracorporeal Membrane Oxygenation
47. The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry
48. Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy
49. Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study
50. Older Adults, “Malignant” Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.